The Patent Finder

Imago Pharmaceuticals, Inc.

Also on record
Records under this name other than patents Imago Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 7 of 7 · Back to Imago Pharmaceuticals, Inc.

PatentTitleStatus Expires Confidence
US 9,884,828Substituted cinnolines as inhibitors of LRRK2 kinase activity
Lapsed on the fee record
Ended Feb 6, 2026 · From the USPTO record
Lapsed on the fee recordEnded Feb 6, 2026From the USPTO record
US 8,450,363Inhibitors of Jun N-Terminal Kinase
Lapsed on the fee record
Ended May 28, 2025 · High confidence
Lapsed on the fee recordEnded May 28, 2025High confidence
US 10,766,954Therapeutic antibodies for treatment of neurodegeneration
Lapsed on the fee record
Ended Sep 8, 2024 · From the USPTO record
Lapsed on the fee recordEnded Sep 8, 2024From the USPTO record
US 9,073,891Inhibitors of Jun N-Terminal Kinase
Lapsed on the fee record
Ended Jul 7, 2023 · High confidence
Lapsed on the fee recordEnded Jul 7, 2023High confidence
US 9,796,706Inhibitors of Jun N-terminal kinase
Lapsed on the fee record
Ended Oct 24, 2021 · From the USPTO record
Lapsed on the fee recordEnded Oct 24, 2021From the USPTO record
US 9,493,485Spirocyclic Dihydro-Thiazine and Dihydro-Oxazine Bace Inhibitors, and Compositions and Uses Thereof
Lapsed on the fee record
Ended Nov 15, 2020 · High confidence
Lapsed on the fee recordEnded Nov 15, 2020High confidence
US 7,790,365Assays for Modulators of Parkin Activity Using S5A as a Parkin Substrate
Lapsed on the fee record
Ended Sep 7, 2018 · High confidence
Lapsed on the fee recordEnded Sep 7, 2018High confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited